Eargo has raised $71 million in a series E round of funding. The round was led by Gilde Healthcare and Longitude Capital, with participation from New Enterprise Associates (NEA), the Charles and Helen Schwab Foundation, and Nan Fung Life Sciences.

Eargo is a Silicon Valley-based consumer medical device company focused on innovative hearing solutions. The company created nature-inspired, patented Flexi Fibers and believes that hearing technologies should feel natural, work in harmony with the ear, and fit the user's lifestyle, not the other way around. Eargo believes that caring for your hearing health should not come at the expense of your lifestyle or appearance. The company's team comes from Stanford, MIT, Harvard and Cambridge, and includes medical and consumer technology executives and advisors from Apple, Yahoo, Match.com and large hearing device manufacturers Phonak and GN ReSound. Eargo was co-founded by the father and son team of Dr. Florent Michel and Raphael Michel along with Daniel Shen, and is backed by leading venture capital firms, including NEA, Maveron, Dolby Family Ventures, Crosslink Capital, Birchmere Ventures, Montage Ventures, Peterson Ventures, and Red Sea Ventures.